EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genome‐wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome

Kang-Hsien Fan, Ruyu Shi iD, Asma Naseer Cheema, Lam-Ha T Dang, Laura Xicota, Sharon Krinsky-McHale, M Muaaz Aslam, Narges Zafari, Vibha Acharya, Eleanor Feingold, Charles M Laymon, Ann Cohen und 8 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Kang-Hsien Fan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Down Syndrome, tau Proteins, Genome-Wide Association Study. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Disease Research Centers Program, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Plasma biomarkers in Down syndrome (DS) accurately detect Alzheimer's disease (AD) pathology. This study aimed to identify genetic loci associated with plasma tau biomarkers (phosphorylated tau [p‐tau]181, p‐tau217, total tau [t‐tau]) and tau positron emission tomography (PET) in DS. METHODS We examined 375 people with DS from the Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS) with data on all four tau biomarkers, and 133 subjects from another study of DS with plasma t‐tau. Single‐trait and multi‐trait genetic association analyses were conducted. AD polygenic risk scores (PRSs) were tested with tau biomarkers. RESULTS Three genome‐wide significant associations were identified for p‐tau181: TUBAP/ rs76523946, P = 2.21E‐08; CTNND2 /rs142510573, P = 3.04E‐08; CLSTN2/ rs112448655, P = 3.04E‐08, and one for t‐tau ( JHY/ rs77264104, P = 2.84E‐08). AD PRS was associated with higher concentrations of tau PET ( β = 0.30, P = 6.57E‐04), p‐tau217 (β = 0.11, P = 4.10E‐02), and t‐tau ( β = 0.12, P = 3.60E‐02). DISCUSSION These data indicate the presence of novel genetic loci in DS affecting plasma tau biomarkers and that AD risk PRS may modify tau neuroimaging and plasma biomarkers in DS. Highlights Four loci were linked to plasma total tau (t‐tau) or phosphorylated tau (p‐tau)181 with genome‐wide significance. JHY /rs77264104 stays genome‐wide significant for plasma t‐tau in a meta genome‐wide association study (GWAS). Alzheimer's disease (AD) polygenic risk score is associated with tau positron emission tomography (PET), regardless of apolipoprotein E genotype and region. Tau‐PET genes in Down syndrome (DS) are enriched in the cerebrospinal fluid phosphorylated tau Alzheimer's disease dementia GWAS catalog. T‐tau genes in DS are enriched in a verbal memory GWAS catalog within a mild cognitive impairment cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down Syndrometau ProteinsGenome-Wide Association StudyHumansBiomarkersMaleFemalePositron-Emission TomographyNeuroimagingAdultAlzheimer DiseaseMiddle Aged

Stichwörter der Autor:innen

Alzheimer's diseaseDown syndromegenome‐wide association studynovel genetic locitau biomarkerstrisomy 21

Substanzen

tau ProteinsBiomarkersMAPT protein, human

Autor:innen und Institutionen

  • Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Sergievsky Center, Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • Department of Psychology, New York Institute for Basic Research, Staten Island, New York, USA.
  • Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.

ORCID-Profile: Ruyu Shi

Förderung

  • NIA NIH HHS
  • Alzheimer's Disease Research Centers Program
  • NICHD NIH HHS
  • NCATS NIH HHS
  • Eunice Kennedy Shriver Intellectual and Developmental Disability Research Centers Program
  • National Center for Advancing Translational Sciences
  • National Institute on Aging

Zitieren

APA

Fan, K. H., Shi, R., Cheema, A. N., Dang, L. T., Xicota, L., Krinsky-McHale, S., Aslam, M. M., Zafari, N., Acharya, V., Feingold, E., Laymon, C. M., Cohen, A., Handen, B. L., Christian, B. T., Head, E., Mapstone, M. E., Alzheimer's Biomarker Consortium – Down Syndrome (ABC‐DS), Cruchaga, C., Lee, J. H., & Kamboh, M. I. (2025). Genome‐wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70398

Vancouver

Fan KH, Shi R, Cheema AN, Dang LT, Xicota L, Krinsky-McHale S, et al. Genome‐wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70398

BibTeX
@article{Fan2025,
  author = {Fan, Kang-Hsien and Shi, Ruyu and Cheema, Asma Naseer and Dang, Lam-Ha T and Xicota, Laura and Krinsky-McHale, Sharon and Aslam, M Muaaz and Zafari, Narges and Acharya, Vibha and Feingold, Eleanor and Laymon, Charles M and Cohen, Ann and Handen, Benjamin L and Christian, Bradley T and Head, Elizabeth and Mapstone, Mark E and Alzheimer's Biomarker Consortium – Down Syndrome (ABC‐DS), Alzheimer's Biomarker Consortium – Down Syndrome (ABC‐DS) and Cruchaga, Carlos and Lee, Joseph H and Kamboh, M Ilyas},
  title = {Genome‐wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70398}
}
Kostenlos starten →